| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.56B | $1.47B | $1.40B |
| YoY Revenue Growth % | +6.4% | +4.9% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.61B | $2.29B | $2.30B |
| Operating Margin % | 167.0% | 155.9% | 164.4% |
| Net Income (GAAP) | $2.21B | $1.94B | $1.95B |
| EBITDA (Normalized) | $2.82B | $2.40B | $2.35B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.48B | $1.84B | $2.66B |
| Capital Expenditures (CapEx) | $267.0M | $143.0M | $63.0M |
| Free Cash Flow (FCF) | $2.21B | $1.69B | $2.59B |
| FCF Margin % | 141.8% | 115.3% | 185.3% |
| Return on Invested Capital (ROIC %) | 2.3% | 2.3% | 17.0% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $90.33B | $83.00B | $4.14B |
| Total Stockholders' Equity | $24.34B | $19.74B | $8.50B |